Danielle D. Durham

Danielle D. Durham

Auto-generated profile, based on publicly available information

Danielle D. Durham

The Carolinas Center for Medical Excellence, Cary, North Carolina

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JCJeffrey M. Caterino
Jeffrey M. Caterino
DADavid Adler
David Adler
DDDanielle D. Durham
Danielle D. Durham
SYSai-Ching Jim Yeung
Sai-Ching Jim Yeung
MHMatthew F. Hudson
Matthew F. Hudson
GLGary H. Lyman
Gary H. Lyman
Patients with cancer account for more than 4.5 million US emergency department (ED) visits annually.1,2 This estimate, derived from ED diagnostic codes, likely underestimates the true annual incidence of cancer-related ED visits among the 15.5 million US residents with cancer.3 Approximately two-thirds of ED visits by patients with cancer result in hospital admission,4,5 affirming the ED as a critical portal addressing acute illness issues and the continuum of cancer management.

1 July 2013 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
SMSasha A. McGee
Sasha A. McGee
DDDanielle D. Durham
Danielle D. Durham
CTChiu-Kit Tse
Chiu-Kit Tse
RMRobert C. Millikan
Robert C. Millikan
Background: Timeliness of care may contribute to racial disparities in breast cancer mortality. African American women experience greater treatment delay than White women in most, but not all studies. Understanding these disparities is challenging as many studies lack patient-reported data and use administrative data sources that collect limited types of information. We used interview and medical record data from the Carolina Breast Cancer Study (CBCS) to identify determinants of delay and assess whether disparities exist between White and African American women (n = 601). Methods: The CBCS is a population-based study of North Carolina women. We investigated the association of demographic and socioeconomic characteristics, healthcare access, clinical factors, and measures of emotional and functional well-being with treatment delay. The association of race and selected characteristics with delays of more than 30 days was assessed using logistic regression. Results: Household size, losing a job due to one's diagnosis, and immediate reconstruction were associated with delay in the overall population and among White women. Immediate reconstruction and treatment type were associated with delay among African American women. Racial disparities in treatment delay were not evident in the overall population. In the adjusted models, African American women experienced greater delay than White women for younger age groups: OR, 3.34; 95% confidence interval (CI), 1.07–10.38 for ages 20 to 39 years, and OR, 3.40; 95% CI, 1.76–6.54 for ages 40 to 49 years. Conclusions: Determinants of treatment delay vary by race. Racial disparities in treatment delay exist among women younger than 50 years. Impact: Specific populations need to be targeted when identifying and addressing determinants of treatment delay. Cancer Epidemiol Biomarkers Prev; 22(7); 1227–38. ©2013 AACR.

1 July 2014 in North Carolina Medical Journal
Verified
Journal Article
Open access
PDF file
SWStephanie B Wheeler
Stephanie B Wheeler
TKTzy-Mey Kuo
Tzy-Mey Kuo
DDDanielle Durham
Danielle Durham
BFBrian Frizzelle
Brian Frizzelle
KRKatherine Reeder-Hayes
Katherine Reeder-Hayes
AMAnne-Marie Meyer
Anne-Marie Meyer
BACKGROUND Distance to oncology service providers and rurality may affect receipt of guideline-recommended radiation therapy (RT), but the extent to which these factors affect the care of Medicare-insured patients is unknown.

1 December 2010 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
ASAnna P. Schenck
Anna P. Schenck
FRFranziska S. Rokoske
Franziska S. Rokoske
DDDanielle D. Durham
Danielle D. Durham
JCJohn G. Cagle
John G. Cagle
LHLaura C. Hanson
Laura C. Hanson
Context: In 2008, the Centers for Medicare & Medicaid Services (CMS) required U.S. hospices to implement comprehensive quality improvement programs. CMS contracted with the Quality Improvement Organization in North and South Carolina to develop quality measures and instruments to assess hospice and palliative care quality. Objectives: To develop a set of quality measures, with complete specifications, and data collection tools for use by hospice and palliative care providers in quality improvement. Methods: Quality measures were identified from: published literature, the National Quality Forum, CMS measures, the National Quality Measures Clearinghouse, and measures submitted by two national hospice organizations. Available data on the quality measures were gathered and pilot data were collected for measures with no availble data. A Technical Expert Panel (TEP) rated quality measures on: importance, scientific soundness, feasibility and usability, using numeric scores for each dimension. Scores for quality measures were averaged across dimensions and across TEP members to identify measures for further development. Results: Of 174 measures identified, 88 were determined appropriate to the setting and were reviewed and rated by the TEP. Measures with overall scores ≥75th percentile (n = 23), measures with high importance scores (n = 7), measures for under-represented domains (n = 2), and process measures antecedent to TEP identified measures (n = 2), and were selected. Conclusions: Specifications and data collection tools are available for 34 PEACE quality measures that were highly rated by experts in hospice and palliative care. Future research should assess the scientific soundness and responsiveness of these measures to quality improvement.

1 September 2019 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
DADavid Adler
David Adler
BABeau Abar
Beau Abar
DDDanielle D. Durham
Danielle D. Durham
ABAveh Bastani
Aveh Bastani
SBSteven L. Bernstein
Steven L. Bernstein
JCJeffrey M. Caterino
Jeffrey M. Caterino